Liver transplant waitlists can range from 30 days to over five years. Developing treatments that spur liver regeneration could help reduce demand for scarce organs.
Shares of consumer-products company Kenvue Inc.rose the most in more than two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to ...
Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's plans for Kenvue at an investor conference tomorrow. Shares of Kenvue (KVUE) took off Monday morning on indications ...